2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Arterial Occlusive Diseases in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roviezzo, F | 1 |
| Cuzzocrea, S | 1 |
| Di Lorenzo, A | 1 |
| Brancaleone, V | 1 |
| Mazzon, E | 1 |
| Di Paola, R | 1 |
| Bucci, M | 1 |
| Cirino, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Remote Ischemic Preconditioning on Restenosis Post Lower Limb Revascularization Angioplasty: A Pilot Randomized Control Trial[NCT02406131] | 40 participants (Anticipated) | Interventional | 2018-04-30 | Suspended (stopped due to logistic issues - no available scans for participants at the moment need to postponed starting dates) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Protective role of PI3-kinase-Akt-eNOS signalling pathway in intestinal injury associated with splanchnic artery occlusion shock.
Topics: Animals; Arterial Occlusive Diseases; Benzoquinones; Blotting, Western; Cell Adhesion Molecules; Chr | 2007 |